Holocene Advisors
ARNA

Holocene Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Holocene Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-287,500
Closed -$18.1M – 823
2020
Q2 		$18.1M Buy
+287,500
New +$15.8M 0.16% 155

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Holocene Advisors's ARNA Position: Q3 2021 in Review

Holocene Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 1,224,937 shares — an estimated $83.5M sold.

Holocene Advisors first reported a position in ARNA in Q1 2020 and held it in 6 quarters. The position peaked at $83.5M in Q2 2021. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

  • Holocene Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • Holocene Advisors sold 1,224,937 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $83.5M.
  • Holocene Advisors first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 6 quarters.
  • Holocene Advisors's Arena Pharmaceuticals Inc position peaked at $83.5M in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on Holocene Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.